Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Collplant Biotechnologies Ltd ADR (CLGN)

Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,490
  • Shares Outstanding, K 11,453
  • Annual Sales, $ 10,960 K
  • Annual Income, $ -7,020 K
  • 60-Month Beta 0.09
  • Price/Sales 5.09
  • Price/Cash Flow N/A
  • Price/Book 2.39
Trade CLGN with:

Options Overview Details

View History
  • Implied Volatility 53.06% ( +19.56%)
  • Historical Volatility 45.75%
  • IV Percentile 27%
  • IV Rank 17.53%
  • IV High 264.40% on 04/05/24
  • IV Low 8.15% on 03/19/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 20
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 1.67
  • Today's Open Interest 16
  • Open Int (30-Day) 12

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.35
  • Number of Estimates 1
  • High Estimate -0.35
  • Low Estimate -0.35
  • Prior Year 0.49
  • Growth Rate Est. (year over year) -171.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.60 +5.33%
on 06/20/24
6.22 -22.15%
on 05/23/24
-1.26 (-20.57%)
since 05/21/24
3-Month
4.60 +5.33%
on 06/20/24
6.75 -28.22%
on 05/09/24
-0.18 (-3.49%)
since 03/21/24
52-Week
4.22 +14.81%
on 03/06/24
8.90 -45.56%
on 06/26/23
-2.74 (-36.08%)
since 06/21/23

Most Recent Stories

More News
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 4.84 (-0.51%)
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million

Received in July 2023, $10 million from partner, AbbVie, for achieving a major milestone in the second quarter, for the clinical-phase dermal filler product in...

CLGN : 4.84 (-0.51%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 4.84 (-0.51%)
CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement

/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 4.84 (-0.51%)
CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 4.84 (-0.51%)
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs

Stratasys Ltd. (Nasdaq: SSYS) and CollPlant Biotechnologies (Nasdaq: CLGN) today announced a joint development and commercialization agreement to collaborate on the development of a solution to bio-fabricate...

SSYS : 8.29 (+1.22%)
CLGN : 4.84 (-0.51%)
Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 4.84 (-0.51%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 4.84 (-0.51%)
CollPlant Issues Letter to Shareholders

/PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue...

CLGN : 4.84 (-0.51%)
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results

Partnership with AbbVie to co-develop rhCollagen-based dermal and soft tissue fillers continues to advance according to plan Co-developing 3D bioprinted human...

CLGN : 4.84 (-0.51%)

Business Summary

CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw...

See More

Key Turning Points

3rd Resistance Point 5.26
2nd Resistance Point 5.12
1st Resistance Point 4.98
Last Price 4.84
1st Support Level 4.71
2nd Support Level 4.58
3rd Support Level 4.44

See More

52-Week High 8.90
Fibonacci 61.8% 7.11
Fibonacci 50% 6.56
Fibonacci 38.2% 6.01
Last Price 4.84
52-Week Low 4.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar